Michael Yan

9PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Risk prediction model for brain metastasis risk among patients diagnosed with primary gastrointestinal cancers.

|Jun 15, 2026
Duration of systemic therapy in patients with metastatic EGFR-mutated non-small cell lung cancer and brain metastases.

|Dec 24, 2025
Ultra- and Moderately Hypofractionated Radiotherapy for Inoperable Cholangiocarcinoma: A Single-Institution Retrospective Analysis.

Saheli Saha, Cameron Lee, Zhihui Amy Liu

|Jul 20, 2023
A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma.

Daniel J Herr, Chang Wang, Mishal Mendiratta-Lala

|May 04, 2022
Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies.

Gustavo Arruda Viani, André Guimarães Gouveia, Michael Yan

|Aug 14, 2021
Practical considerations for prostate hypofractionation in the developing world.

Michael Yan, Andre G Gouveia, Fabio L Cury

Pageof 2

Frequent Collaborators

3 joint publications

Fabio Ynoe Moraes

2 joint publications

André Guimarães Gouveia

1 joint publications

Samantha Sigurdson

1 joint publications

Noah Greifer